Ulthera HIFU delivers focused ultrasound to the dermis and fascial layer, tightening the fascia and stimulating collagen regeneration, with a noticeable effect on contour lifting.

Ulthera HIFU is a focused-ultrasound skin-tightening device from the United States. It delivers focused ultrasound energy directly to the dermis and the fascial layer (SMAS), heating to about 60°C to 70°C, tightening the fascia and stimulating collagen regeneration. It is a trusted non-invasive lifting option.
The treatment’s greatest distinctive feature is patented DeepSEE™ real-time ultrasound imaging, which allows skin tissue to be observed during treatment, ensuring energy is delivered to the accurate location and depth. It is one of the few systems that lets the practitioner accurately see the tissue being treated.
Stage one (weakening of elastic fibres): with age, collagen and elastic fibres are lost and break, and the skin sags and becomes lax.
Stage two (ultrasound energy delivery): non-invasive HIFU focuses with precision on the SMAS fascial layer and dermis, initiating regeneration and reorganisation of collagen and elastic fibres.
Stage three (collagen regeneration): results begin to appear about 1 month after treatment, with clear lifting at 2–3 months, and contour lines gradually tightening and rebounding.
There is an initial effect immediately after treatment; results begin to appear at about 1 month; they are most noticeable at 2–3 months; collagen production continues over the following 6 months. Contour improvement may last 18–24 months, or even two years or longer.
Pico picosecond laser mainly targets pigment and skin-quality improvement and pore refinement, and is not primarily for deep collagen tightening; Thermage uses monopolar radiofrequency to heat the dermis about 3–4.3 mm, focusing on overall skin firmness; Ulthera HIFU uses high-energy focused ultrasound on the 3.0 mm dermis and 4.5 mm fascial layer, with more noticeable effect on contour lifting and obvious sagging.
Certified by the US FDA and EU CE, with more than 260,000 real cases worldwide, supported by more than 60 medical studies, 40 professional reports and 100 patents — safety and results are well supported by data.